SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-21-058977
Filing Date
2021-04-30
Accepted
2021-04-30 16:03:50
Documents
4
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2114348d1_pre14a.htm PRE 14A 429911
2 GRAPHIC tm2114348d1img_002.jpg GRAPHIC 4905
3 GRAPHIC tm2114348d1img_004.jpg GRAPHIC 102646
4 GRAPHIC tm2114348d1img_005.jpg GRAPHIC 250786
  Complete submission text file 0001104659-21-058977.txt   924972
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-20713 | Film No.: 21877744
SIC: 2836 Biological Products, (No Diagnostic Substances)